3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasms
8
Melanoma
6
Carcinoma, Non-Small-Cell Lung
5
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Lymphoma
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Nasopharyngeal Carcinoma
2
Liver Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Advanced Solid Tumors
2
Advanced Solid Tumor
2
Uterine Cervical Neoplasms
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma
1
Primary Condition: Advanced Tumors
1
Neuroendocrine Tumors
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
1
Kidney Neoplasms
1
High-Risk Resectable NSCLC
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Interventions
Cisplatin
3
Fluorouracil
2
toripalimab
1
pembrolizumab
1
motexafin gadolinium
1
dl1520
1
Taxes
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
NVP-BKM120
1
MVA vaccine
1
L 778,123
1
Irinotecan
1
Immunohistochemistry
1
Gemcitabine
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
EBV-associated membrane antigen, Epstein-Barr virus
1
Doxorubicin
1
Docetaxel
1
Biopsy
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Nasopharyngeal Neoplasms
×
toripalimab
×
Clear all
NCT07625423
2026-06-04
EDS01 HN
West China Hospital
Phase 1
Recruiting
9 enrolled